"Rescue administration" of intracoronary thrombolytic therapy for drug-eluting stent thrombosis

C Y Karabay1, G Kocabay, A Kalayci

  • 1Department of Cardiology, Kartal Kosuyolu Yuksek Ihtisas Heart Education and Research Hospital, Kartal, Istanbul, Turkey.

Herz
|August 17, 2013
PubMed

Insights

Stent thrombosis, a serious complication, may require treatment beyond mechanical thrombectomy. Intracoronary thrombolysis shows promise for patients with drug-eluting stent thrombosis when mechanical methods fail.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Thrombosis Research

Background:

  • Stent thrombosis is a life-threatening complication following coronary stent placement.
  • Drug-eluting stents are associated with stent thrombosis, leading to myocardial infarction or death.
  • Current treatment guidelines for failed mechanical thrombectomy in stent thrombosis are not well-established.

Observation:

  • A case of drug-eluting stent thrombosis occurred in a patient.
  • Mechanical thrombectomy was attempted but proved unsuccessful in resolving the thrombosis.
  • Intracoronary thrombolysis was administered as a subsequent treatment strategy.

Findings:

  • Intracoronary thrombolysis was effective in treating stent thrombosis after mechanical thrombectomy failure.
  • This represents a novel therapeutic approach for a challenging clinical scenario.
  • The successful use of intracoronary thrombolysis in this context is reported for the first time.

Implications:

  • Intracoronary thrombolysis may be a viable treatment option for refractory stent thrombosis.
  • This case highlights the need for further research into advanced treatment strategies for stent thrombosis.
  • Clinicians should consider intracoronary thrombolysis in select patients with failed mechanical thrombectomy for stent thrombosis.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...